Targretin is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Bausch Health Us Llc. The primary component is Bexarotene.
| Product ID | 0187-5526_15c08420-c6fd-4880-bc99-1f93c25dbc52 |
| NDC | 0187-5526 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Targretin |
| Generic Name | Bexarotene |
| Dosage Form | Capsule, Liquid Filled |
| Route of Administration | ORAL |
| Marketing Start Date | 1999-12-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021055 |
| Labeler Name | Bausch Health US LLC |
| Substance Name | BEXAROTENE |
| Active Ingredient Strength | 75 mg/1 |
| Pharm Classes | Retinoid [EPC],Retinoids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1999-12-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021055 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1999-12-29 |
| Ingredient | Strength |
|---|---|
| BEXAROTENE | 75 mg/1 |
| SPL SET ID: | 1d056725-0576-4338-8089-6336e768ccdc |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0187-5525 | Targretin | bexarotene |
| 0187-5526 | Targretin | bexarotene |
| 0054-0399 | Bexarotene | bexarotene |
| 0378-6955 | Bexarotene | Bexarotene |
| 0591-2832 | bexarotene | bexarotene |
| 0832-0285 | Bexarotene | Bexarotene |
| 42292-007 | Bexarotene | Bexarotene |
| 43975-315 | Bexarotene | Bexarotene |
| 68682-002 | bexarotene | bexarotene |
| 68682-003 | bexarotene | bexarotene |
| 69238-1250 | Bexarotene | Bexarotene |
| 69238-2088 | Bexarotene | Bexarotene |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TARGRETIN 75840727 2464596 Live/Registered |
VALEANT PHARMACEUTICALS INTERNATIONAL, I 1999-11-04 |
![]() TARGRETIN 74700262 2149626 Live/Registered |
VALEANT PHARMACEUTICALS INTERNATIONAL, I 1995-07-12 |